Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Tazarotene gel may be more effective for acne than adapalene gel.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Abatacept may help some people with alopecia areata regrow hair.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Oral isotretinoin effectively stabilizes frontal fibrosing alopecia.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

An adult had a rare scalp infection in the forehead area, treated successfully with itraconazole.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

EGFR-TKIs can cause significant skin, nail, and organ side effects.